je.st
news
FDA probes cognitive impact of new cholesterol drugs
2014-03-08 17:04:55| Biotech - Topix.net
T he Food and Drug Administration has asked Regeneron Pharmaceuticals Inc and Sanofi SA to assess potential neurocognitive side effects of their experimental cholesterol drug, Sanofi said in its annual report on Friday.
Tags: impact
drugs
cognitive
cholesterol
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|